Roche
RO.SW
#42
Rank
NZ$617.77 B
Marketcap
NZ$775.35
Share price
-1.03%
Change (1 day)
35.80%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$35.70

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$35.70. In 2025 the company made an earnings per share (EPS) of NZ$35.70 an increase over its 2024 EPS that were of NZ$20.10.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$35.7077.67%
2024NZ$20.10-32.84%
2023NZ$29.921.95%
2022NZ$29.35-6.29%
2021NZ$31.32-5.53%
2020NZ$33.1516.56%
2019NZ$28.4430.3%
2018NZ$21.8320.22%
2017NZ$18.16-5.81%
2016NZ$19.284.62%
2015NZ$18.42-5.13%
2014NZ$19.42-25.05%
2013NZ$25.9121.73%
2012NZ$21.293.82%
2011NZ$20.508.16%
2010NZ$18.9623.72%
2009NZ$15.32-12.31%
2008NZ$17.47-0.34%
2007NZ$17.5332.13%
2006NZ$13.2742.56%
2005NZ$9.31-22.7%
2004NZ$12.04132.85%
2003NZ$5.17-150.5%
2002NZ-$10.24-209.09%
2001NZ$9.39-57.03%
2000NZ$21.8453.29%
1999NZ$14.2531.24%
1998NZ$10.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.26-57.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.26-65.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.29-93.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.30-82.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$25.30-29.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.47-87.48%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$5.77-83.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.25-82.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.79-80.98%๐Ÿ‡ฌ๐Ÿ‡ง UK